Inventaire - your friends and communities are your best library

Neisseria meningitidis Group A IgG1 and IgG2 Subclass Immune Response in African Children Aged 12-23 Months Following Meningococcal Vaccination

author

Ray Borrow

Samba Sow

Brian D. Plikaytis

George M Carlone

Helen Findlow

published in: Clinical Infectious Diseases

date of publication: 2015-11-01

language: English

main subject: Neisseria meningitidis

Cites articles 34

Date

Title

Authors

2011-11-01

Glycoconjugate vaccines and immune interactions, and implications for vaccination schedules

Ray Borrow, Ron Dagan
2011

Age-related immunity to meningococcal serogroup C vaccination: an increase in the persistence of IgG2 correlates with a decrease in the avidity of IgG

Elisabeth Sanders
2011-07-13

Meningococcal group C and w135 immunological hyporesponsiveness in african toddlers

Ray Borrow, Samba Sow, Richard Adebayo Adegbola, Helen Findlow
2011-06-01

Eliminating epidemic Group A meningococcal meningitis in Africa through a new vaccine
2011-06-01

Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans.

Ray Borrow, Richard Adebayo Adegbola, Samba Sow, Brian D. Plikaytis, George M Carlone, Helen Findlow
2010-05-14

The early kinetics of circulating pneumococcal-specific memory B cells following pneumococcal conjugate and plain polysaccharide vaccines in the elderly.

Sheila Keating, David Goldblatt, Elizabeth Miller, Jo Southern
2009-10-01

Kinetics of antibody responses after primary immunization with meningococcal serogroup C conjugate vaccine or secondary immunization with either conjugate or polysaccharide vaccine in adults

Elisabeth Sanders
2007-05-08

Safety, immunogenicity, and antibody persistence of a new meningococcal group A conjugate vaccine in healthy Indian adults

Urmila M. Thatte, Brian D. Plikaytis, George M Carlone, Nithya Gogtay, Helen Findlow
2006-12-01

Long-term protection in children with meningococcal C conjugate vaccination: lessons learned

Ray Borrow, Elizabeth Miller
2006-05-04

CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen-specific memory B cells.

Ly-Mee Yu, Andrew Pollard, Elizabeth A. Clutterbuck, Richard Moxon
2006-04-01

Immunoglobulin G subclass response to a meningococcal quadrivalent polysaccharide-diphtheria toxoid conjugate vaccine

Ray Borrow, Elizabeth Miller, Jo Southern, Helen Findlow
2005-10-01

Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents.

Harry L Keyserling
2004-01-01

Assignment of Neisseria meningitidis serogroups A, C, W135, and Y anticapsular total immunoglobulin G (IgG), IgG1, and IgG2 concentrations to reference sera

Ray Borrow
2004-06-10

Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire

Birte Steiniger, Jean-Laurent Casanova, Sandra Weller, Corinne Cordier, Andreas Rosenwald, Claude-Agnès Reynaud
2002-10-08

Antibody persistence and immunological memory at age 4 years after meningococcal group C conjugate vaccination in children in the United kingdom.

Ray Borrow, Nick Andrews, Elizabeth Miller, Jo Southern, David Goldblatt
2002-11-01

Prior meningococcal A/C polysaccharide vaccine does not reduce immune responses to conjugate vaccine in young adults
2001-03-01

Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection

Nick Andrews, David Goldblatt
2001-07-10

Influence of prior meningococcal C polysaccharide vaccination on the response and generation of memory after meningococcal C conjugate vaccination in young children

Peter Richmond, Nick Andrews, Elizabeth Miller, David Goldblatt
2001-09-25

Avidity and subclasses of IgG after immunization of infants with an 11-valent pneumococcal conjugate vaccine with or without aluminum adjuvant

Helena Käyhty
2000-02-01

Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine

Peter Richmond, Elizabeth Miller
1999-08-01

Immune response to revaccination with meningococcal A and C polysaccharides in Gambian children following repeated immunisation during early childhood

Jonathan Deeks, George M Carlone
1999-09-01

Age-associated differences in immunoglobulin G1 (IgG1) and IgG2 subclass antibodies to pneumococcal polysaccharides following vaccination
1999-07-01

Manson Lecture. Meningococcal meningitis in Africa.
1999-06-01

Elderly immune response to a TI-2 antigen: heavy and light chain use and bactericidal activity to Neisseria meningitidis serogroup C polysaccharide

George M Carlone
1998-08-01

Infant B cell responses to polysaccharide determinants
1996-05-01

Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide, vaccines.

Kate O'Brien
1995-01-01

Human immunoglobulin G (IgG) Fc receptor IIA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils
1995-03-01

A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants

Claire V. Broome, George M Carlone
1992-11-01

Complement activation by polyclonal immunoglobulin G1 and G2 antibodies against Staphylococcus aureus, Haemophilus influenzae type b, and tetanus toxoid
1979-01-01

IgG subclass levels in infancy and childhood
1975-12-01

Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants
1971-01-01

Meningococcal infections. 5. Duration of polysaccharide-vaccine-induced antibody

Article - wd:Q36265012

Welcome to Inventaire

the library of your friends and communities

learn more